Sir-Spheres Selective Radiation Therapy Approvable For Liver Cancer - Panel
This article was originally published in The Gray Sheet
Executive Summary
Sirtex Medical's Sir-Spheres embolic radiation therapy device for liver cancer is beneficial over traditional chemotherapy - despite the lack of a statistically insignificant increase in patient survival - because it offers a slower time to disease progression, FDA advisory panel members agreed at a Nov. 6 meeting in Rockville, Maryland.